Consensus Centene Corporation Sao Paulo

Stocks

C1NC34

BRC1NCBDR000

Managed Healthcare

Delayed Sao Paulo 22:30:31 28/10/2026 +04			5-day change	1st Jan Change
359.64 ^BRL	-2.44%		-2.44%	+62.01%

03:39pm	AI data center stocks dip, renewables surge after Democrat sweep in US midterm elections	RE
03:24pm	US Stock Futures Rally as Democrats Take Control of Congress	MT

efae5.ZLaPgjl_snyvRr3bELlGK89omrFg3Xx8psojhYfOs_4.N8zit0MR9R3mLdaOf8sLe6YHrPJX6EUZ4Yxs5PW33owjgfnMWh3VNuIK9A~739920ca932ac2feb755df06f4d1a2ba

Analysts' recommendations: Centene Corporation

11-02	Goldman Sachs Adjusts Centene Price Target to $62 From $56	MT
11-02	Deutsche Bank Adjusts Centene Price Target to $87 From $85, Maintains Buy Rating	MT
11-02	Truist Adjusts Price Target on Centene to $82 From $80, Maintains Buy Rating	MT
10-28	UBS Adjusts Price Target on Centene to $78 From $70, Maintains Neutral Rating	MT
09-11	BofA Securities Adjusts Centene Price Target to $80 From $78	MT
08-11	Argus Research Upgrades Centene to Buy From Hold, $80 Price Target	MT
08-04	JPMorgan Adjusts Price Target on Centene to $67 From $60, Maintains Neutral Rating	MT
08-03	Bernstein Adjusts Centene Price Target to $79 From $68, Maintains Outperform Rating	MT
07-29	Centene's Strong Q2 Beat Overshadowed by Delayed Medicaid Margin Recovery, RBC Says	MT
07-29	UBS Adjusts Price Target on Centene to $70 From $61, Maintains Neutral Rating	MT
07-29	Jefferies & Co Adjusts Centene Price Target to $59 From $48, Maintains Hold Rating	MT
07-29	Truist Lifts Price Target on Centene to $80 From $78, Keeps Buy Rating	MT
07-29	Goldman Sachs Adjusts Centene Price Target to $56 From $40, Maintains Sell Rating	MT
07-29	Morgan Stanley Adjusts Centene Price Target to $66 From $57, Maintains Equal Weight Rating	MT
07-29	Baird Adjusts Centene Price Target to $66 From $46, Maintains Neutral Rating	MT
07-29	Deutsche Bank Adjusts Centene Price Target to $85 From $80, Maintains Buy Rating	MT
07-29	Analyst recommendations: Carmax, Kla Corporation, Nasdaq, Fortinet, PayPal…
07-28	Barclays Raises Centene Price Target to $80 From $75	MT
07-14	Truist Raises Price Target on Centene to $78 From $71, Keeps Buy Rating	MT
07-14	TD Cowen Adjusts Price Target on Centene to $65 From $47, Maintains Hold Rating	MT
07-13	Mizuho Adjusts Price Target on Centene to $69 From $63, Maintains Neutral Rating	MT
07-13	Wells Fargo Adjusts Price Target on Centene to $69 From $56, Maintains Equalweight Rating	MT
07-09	RBC Trims Price Target on Centene to $71 From $70, Maintains Sector Perform Rating	MT
07-07	Cantor Fitzgerald Adjusts Centene Price Target to $75 From $60	MT
06-23	Centene's Multi-Year Recovery Underway, RBC Says	MT

More recommendations

Other Managed Healthcare

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	UNITEDHEALTH GROUP INC.					+17.85%
	ELEVANCE HEALTH, INC.					+16.59%
	CIGNA					+15.86%
	HUMANA INC.					+11.31%
	CENTENE CORPORATION					+10.4%
	MOLINA HEALTHCARE, INC.					+5.62%
	CLOVER HEALTH INVESTMENTS, CORP.					+28.21%
	PROGYNY, INC.					+18.43%
	ALIGNMENT HEALTHCARE, INC.					+46.03%
	Average					+18.92%
	Weighted average by Cap.					+16.41%